Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
22.19
-0.62 (-2.72%)
At close: Sep 23, 2026, 4:00 PM EDT
22.17
-0.02 (-0.09%)
After-hours: Sep 23, 2026, 5:18 PM EDT
Beta Bionics Market Cap
Beta Bionics has a market cap or net worth of $1.17 billion as of September 23, 2026. Its market cap has increased by 17.34% in one year.
Market Cap
1.17B
Enterprise Value
994.15M
1-Year Change
17.34%
Ranking
Category
Stock Price
$22.19
ChartMarket Cap Chart
Since the IPO on January 30, 2025, Beta Bionics's market cap has increased from $695.12M to $1.17B, an increase of 68.05%. That is a compound annual growth rate of 37.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 1.17B | -12.92% |
| Dec 31, 2025 | 1.34B | 92.98% |
| Jan 30, 2025 | 695.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alphatec Holdings | 1.60B |
| CONMED | 1.38B |
| Integra LifeSciences Holdings | 1.25B |
| Tandem Diabetes Care | 1.22B |
| Artivion | 1.18B |
| Bioventus | 1.15B |
| IRADIMED CORPORATION | 1.11B |
| Enovis | 1.06B |